Langenfeld, Canada

Anne Décor

This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anne Décor. Retrieved from https://idiyas.com/inventor/anne-décor

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Anne Décor

Introduction

Anne Décor is a prominent inventor based in Langenfeld, California. She has made significant contributions to the field of medicine, particularly in the treatment of viral infections. Her work has led to the development of innovative compounds that target cytomegalovirus disease.

Latest Patents

Anne Décor holds a patent for "Inhibitors of cytomegalovirus - Compounds of Formula (I) wherein R, R, R, R, Y, Z, and Z are defined herein, are useful for the treatment of cytomegalovirus disease and/or infection." This patent highlights her dedication to advancing medical treatments and improving patient outcomes.

Career Highlights

Throughout her career, Anne has been associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. Her role at the company has allowed her to focus on research and development, contributing to groundbreaking innovations in the pharmaceutical industry.

Collaborations

Anne has collaborated with notable colleagues, including Carl Thibeault and Jean Rancourt. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of her work.

Conclusion

Anne Décor's contributions to the field of medicine through her innovative patents and collaborations exemplify her commitment to improving healthcare. Her work continues to inspire future advancements in the treatment of viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…